'Hcv treatment' presentation slideshows

CLINCAL COURSE IN HCV

HCV TREATMENT ; THE PROMISING FUTURE Dr MOHAMMED EMAM PROF. GASTROENTROLOGY AND HEPATOLOGY ZAGAZIG UNIVERSITY . Dr MOHAMMED EMAM PROF. GASTROENTROLOGY AND HEPATOLOGY ZAGAZIG UNIVERSITY . CLINCAL COURSE IN HCV. SESSION 4.

654 views • 57 slides

Integrating Hepatitis C and Drug Treatment in a Community-Based Setting

Integrating Hepatitis C and Drug Treatment in a Community-Based Setting. Diana L. Sylvestre, MD O.A.S.I.S. Organization to Achieve Solutions in Substance-Abuse. Who we are:. A nonprofit organization located in Oakland, CA. HIV. TB. STDs. And especially:. Hepatitis C.

626 views • 50 slides

Alcohol Use, Abuse in HIV HIV Quality of Care Advisory Committee Thursday, December 14

Alcohol Use, Abuse in HIV HIV Quality of Care Advisory Committee Thursday, December 14. Joseph Conigliaro, MD, MPH Center for Enterprise Quality and Safety University of Kentucky. Objectives. To review present data assessing the role of alcohol use and abuse among patients with HIV/AIDS

622 views • 47 slides

Barriers to HCV Therapy: Improving Access to Care

Barriers to HCV Therapy: Improving Access to Care. Michael W. Fried, M.D. Professor of Medicine Director, UNC Liver Center University of North Carolina at Chapel Hill. Barriers to Treating HCV. Societal. Type of health care system Unemployment. Stigma Disadvantaged status Poverty.

577 views • 42 slides

Hepatitis C Drug Pipeline

Hepatitis C Drug Pipeline. HCV WORLD CAB ? FEBRUARY 2014 BANGKOK, THAILAND. When to Treat HCV. HCV Direct-Acting Antivirals ( DAAs ) in development. Know your epidemic: what matters HCV treatment overview : now & in the near future Strategies for scaling up.

547 views • 31 slides

Treatment of HCV in Cirrhotic Patient

403 views • 30 slides

Matt Hickman Natasha Martin, Peter Vickerman, Daniela De Angelis

The primary prevention of hepatitis C among injectors: model projections of the impact of opiate substitution therapy, needle exchange and antiviral therapy. Matt Hickman Natasha Martin, Peter Vickerman, Daniela De Angelis. Primary Prevention of HCV. Epidemiology Intervention Effectiveness

505 views • 30 slides

Treatment of HCV infection among active IDUs

Jason Grebely, PhD Lecturer Viral Hepatitis Clinical Research Program National Centre in HIV Epidemiology and Clinical Research University of New South Wales. Treatment of HCV infection among active IDUs. Hepatitis C treatment. Sustained virologic response. ?. PEG-IFN+RBV

394 views • 26 slides

Treatment of HCV infection among active IDUs

Jason Grebely, PhD Lecturer Viral Hepatitis Clinical Research Program National Centre in HIV Epidemiology and Clinical Research University of New South Wales. Treatment of HCV infection among active IDUs. Hepatitis C treatment. Sustained virologic response. ?. PEG-IFN+RBV

369 views • 26 slides

Epidemiology and prevention of HCV in IDUs

398 views • 25 slides

Mental Health, Substance Use, and HIV/HCV coinfection treatment

Mental Health, Substance Use, and HIV/HCV coinfection treatment. Jeffrey J. Weiss, PhD Assistant Professor, Psychiatry Mount Sinai School of Medicine New York, New York, USA. Co-Occurrence of HIV, HCV, Mental Health & Substance Use Problems. Mental Health. HCV. HIV. Substance Use (IDU).

304 views • 21 slides

WHAT FUTURE FOR RIBAVIRIN?

WHAT FUTURE FOR RIBAVIRIN?. Mitchell L Shiffman, MD Chief, Hepatology Section Medical Director, Liver Transplant Program Virginia Commonwealth University Medical Center Richmond, VA. ROLE OF RIBAVIRIN IN HCV TREATMENT MECHANISM OF ACTION. Guanosine analog

349 views • 21 slides

Treating Hepatitis C in Methadone Patients: With Planning, it Works!

Treating Hepatitis C in Methadone Patients: With Planning, it Works!. Patricia Perkins, MS, MPH Independent Healthcare Consultant Community Advisory Board Member Organization to Achieve Solutions in Substance-Abuse (O.A.S.I.S.) www.oasisclinic.org.

351 views • 20 slides

HIV / HCV co-infection

HIV / HCV co-infection. Through the eyes of a co-infected hemophiliac . I.D. History-The HCV Diagnosis. More bad news delivered on the heels of an HIV diagnosis. I attend funerals for others I knew through the hemophilia clinic, lost to HIV.

355 views • 19 slides

HCV Infection in Marginalized Populations

HCV Infection in Marginalized Populations. Brian Conway, MD, FRCPC Vancouver Infectious Diseases Centre (VIDC). IDUs will drive the future HCV epidemic in Canada. 300,000 HCV-infected Canadians, including over 180,000 IDUs (60% of prevalent cases)

325 views • 19 slides

Special Considerations: When and What to Start with Viral Hepatitis Coinfections

266 views • 17 slides

STARTVerso 4: High rates of early virologic response in HCV genotype 1/HIV-co-infected patients treated with faldaprevir plus pegIFN and RBV.

244 views • 14 slides

Introduction

262 views • 14 slides

Essraa Bayoumi

Essraa Bayoumi. National Program for the Treatment of Hepatitis C. 1. Eligibility criteria for HCV treatment 2. How patients are screened to determine eligibility for treatment 3. Which eligible patients are actually treated 4. The treatments and interventions applied to each patient

225 views • 4 slides

M.C. Thurnheer 1,2 , S. Wildbolz 1 , U.Breckner 3 , H. Furrer 1

Improving medical care for people who inject drugs in Switzerland: results from an integrated approach to HIV and HCV management. M.C. Thurnheer 1,2 , S. Wildbolz 1 , U.Breckner 3 , H. Furrer 1. Koda Bern: On-site heroin maintenance treatment for PWID

133 views • 4 slides